U.S. Centers for Disease Control & Prevention
Researchers from U.S. Centers for Disease Control & Prevention publish most recent findings
Published in Pharma Investments, Ventures and Law Weekly, June 4th, 2006
This trend article about U.S. Centers for Disease Control & Prevention is an immediate alert from LawRx to identify developing directions of research.
Study 1: Interventions for the primary prevention of perpetration of partner violence were reviewed in a recent issue of Aggression and Violent Behavior.
According to the review from the United States, "There is growing consensus that preventing partner violence requires interventions that begin before partner violence begins. In recent years, a number of evaluations of primary...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- A.P. Pharma, Inc.
A.P. Pharma reports income of $0.75 per share; phase III trial for APF530 initiated - Abiomed, Inc.
Abiomed reports revenue is up 28% to $13.8 million - Acadia Pharmaceuticals, Inc.
Acadia Pharmaceuticals reports quarterly loss of $9.5 million - Aceto Corp.
Aceto announces earnings per share of $0.11 - Adherex Technologies, Inc.
Adherex announces US$6.5 million private placement - Adolor Corp.
Adolor reports loss of $0.42 per share - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
